Status:
COMPLETED
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Lipid Metabolism, Inborn Errors
Heart Disease
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
This is a 6-month study with patients who have the rare disease, sitosterolemia which may result in heart-related diseases. These patients have unusually high absorption of non-cholesterol sterols, re...
Detailed Description
The duration of treatment is 26 weeks.
Eligibility Criteria
Inclusion
- 18 years or older, with a history of elevated sitosterol levels and have received treatment for at least 6 months prior to study entry.
Exclusion
- Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient or interfere with participation in the study.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00092898
Start Date
October 1 2004
End Date
October 1 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.